SCHEMBL19960259

SCHEMBL19960259

O=P(c1ccccc1)(c1ccccc1)c1ccc2c3cc4ccccc4cc3c3nc4ccc(-c5ccccc5)cc4n3c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
KDM4E B2RXH2 2/20 0.38
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
NPM1 P06748 1/20 0.34
ALK Q9UM73 1/20 0.34
TP53 P04637 2/20 0.33
HSD17B10 Q99714 2/20 0.33
AHR P35869 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
HIF1A Q16665 1/20 0.33
ESR1 P03372 4/20 0.32
ESR2 Q92731 4/20 0.32
PDE2A O00408 2/20 0.32
DHODH Q02127 1/20 0.32
METAP2 P50579 1/20 0.31
LMNA P02545 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19960275 1.00 ALDH1A1 (0.38) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL19960264 0.96 ALDH1A1 (0.34) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL19960028 0.93 KDM4E (0.39) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL19960167 0.92 KDM4E (0.41) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL14644083 0.92 ALDH1A1 (0.44) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL20090153 0.92 ALDH1A1 (0.44) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL19960014 0.92 ALDH1A1 (0.43) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL19960007 0.92 ALDH1A1 (0.43) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL19960010 0.91 ALDH1A1 (0.41) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2
SCHEMBL19960269 0.91 PPARG (0.36) ALDH1A1HPGDKDM4EKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 ALDH1A1 750/4885HPGD 2982/4885KDM4E 1997/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 ALDH1A1 750/4885HPGD 2982/4885KDM4E 1997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.